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IntroductIon
Melanoma arises from malignant transformation 
of melanocytes. Besides, it is highly metastatic and 
among the most resistant cancers to treatments [1]. Loss 
of pigmentation in melanoma is common in advanced 
lesions because of dysfunction in melanogenesis proteins. 
Tyrosinase (TYR) and the tyrosinase related proteins 1 and 
2 (TYRP1 and TYRP2 respectively), are the main proteins 
involved in melanogenesis [2].
Melanoma cells produce high amounts of reactive 
oxygen species (ROS) compared with their non-tumoral 
counterpart [3, 4]. ROS participate in tumor development 
by inducing oncogenic mutation and signal transduction 
pathways associated with cell proliferation [5, 6], 
differentiation [7] and the pro-invasive metastatic program 
[7–12]. Antioxidant enzymes, such as superoxide dismutase 
(SOD), catalase, peroxidases and peroxiredoxins, control 
the levels of ROS. H2O2 increases in a wide variety of 
malignant cells through an imbalance in the antioxidant 
system (AOS), characterized by high levels of SOD and 
low levels of H2O2 detoxifying enzymes, as catalase 
[4, 13, 14]. Indeed, tumor cell proliferation is inhibited by 
decreasing H2O2 through catalase. 
Catalase is the main enzyme that dissipates the 
H2O2 produced during melanin synthesis [15]. There is 
a correlation among catalase activity, melanin content 
and TYR activity [15, 16]. Therefore, considering that 
H2O2 inhibits TYR, TYRP1 and TYRP2 [17], the high 
levels of H2O2 associated with low catalase activity in 
melanoma [18–20] would be relevant in the induction of 
the amelanotic phenotype.
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AbstrAct
Advanced melanoma is the most aggressive form of skin cancer. It is highly 
metastatic and dysfunctional in melanogenesis; two processes that are induced by 
H2O2. This work presents a melanoma cell model with low levels of H2O2 induced 
by catalase overexpression to study differentiation/dedifferentiation processes. 
Three clones (A7, C10 and G10) of human A375 amelanotic melanoma cells with 
quite distinct phenotypes were obtained. These clones faced H2O2 scavenging by two 
main strategies. One developed by clone G10 where ROS increased. This resulted 
in G10 migration and metastasis associated with the increased of cofilin-1 and 
CAP1. The other strategy was observed in clone A7 and C10, where ROS levels were 
maintained reversing malignant features. Particularly, C10 was not tumorigenic, while 
A7 reversed the amelanotic phenotype by increasing melanin content and melanocytic 
differentiation markers. These clones allowed the study of potential differentiation and 
migration markers and its association with ROS levels in vitro and in vivo, providing 
a new melanoma model with different degree of malignancy.
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Cell invasion and migration are critical for 
metastasis and indicate poor prognosis. To migrate, cancer 
cells develop invadopodia through actin polymerization/
depolymerization cycles [21–23]. Metastatic cells 
present high levels of cofilin-1, a key regulator of 
actin polymerization. Cofilin-1 severs actin filaments, 
favoring actin polymerization and so migration [24, 25]. 
Overexpression of cofilin-1 was associated with loss of 
cell polarity in colon adenocarcinoma cells [26] and has 
been used as poor prognosis marker related to metastasis in 
lung cancer patients [27, 28]. Adenylyl cyclase-associated 
protein 1 (CAP1) facilitates actin and cofilin-1 recycling, 
essential for cell migration [29, 30]. CAP1 overexpression 
was associated with migration in pancreatic cancer cells 
[31]. However, the behavior of these proteins in melanoma 
has received little attention.
In this study, a differential compensation to H2O2 
scavenging by catalase overexpression in A375 amelanotic 
melanoma cells was demonstrated. Cells responded to 
H2O2 scavenging by two main strategies: increasing ROS, 
which resulted in metastasis or maintaining ROS levels, 
reversing malignant features. Therefore, to overcome 
the inhibition of cell proliferation induced by catalase 
overexpression, cells changed the redox status leading to 
distinct phenotypes ranging from reversion to promotion 
of melanoma malignancy. Finally, this model allowed 
the evaluation in vitro and in vivo of migration related 
proteins and melanocytic differentiation markers and their 
association with oxidative stress levels.
results
characterization of melanoma cells 
overexpressing catalase 
Catalase overexpression on human amelanotic 
melanoma A375 cells gave rise to three clones: A375-A7 
(A7), A375-C10 (C10) and A375-G10 (G10). A375 and A375 
cells transfected with the empty vector (PCDNA3) were used 
as control. An increase in catalase activity and expression was 
observed for all clones vs PCDNA3 (p < 0.05) (Figure 1A–
1C). H2O2 levels decreased in all clones when compared 
to control (p < 0.05), with the unexpected increase in G10 
ROS production (p < 0.05) (Figure 1D–1F). No changes 
were found neither in glutathione peroxidase activity nor 
in peroxiredoxin 2 expression (Supplementary Figure S1). 
These results indicate that catalase overexpression dissipates 
H2O2 in all clones and only G10 induced a redox response 
that increased its basal ROS levels. 
stable expression of catalase down-regulated cell 
proliferation parameters 
Cell proliferation, anchorage-independent cell 
growth and ERK activity decreased in all clones vs control 
(p < 0.05). AKT activity was significantly lower only for 
A7 (Figure 2A–2D). Together, these results confirm that 
catalase overexpression decreases H2O2, inhibiting cell 
proliferation parameters. In view of the similar results 
between PCDNA3 and A375 cells, most in vitro assays 
were performed using only PCDNA3 as control. 
different cell polarity degree was induced by 
catalase overexpression 
Cell polarity, particularly melanoma cell dendricity 
is associated with more differentiated phenotype while 
its disruption is a hallmark of cancer [32–35]. Increased 
polarity was found in A7 vs control (p < 0.05). On the 
contrary, a dramatic loss of polarity was observed in G10 
vs control (p < 0.001). An increase of multipolar cells 
in A7 and apolar cells in G10 was observed vs control 
(< 0.01) (Figure 2E–2F). This indicates higher cell 
differentiation degree in A7, as it resembles melanocytes 
dendritic like-structure [34–36]. Conversely, the apolar 
feature of G10 may be associated to amoeboid migration, 
one of the two main categories of cell movement, 
characteristic of rounded or ellipsoid cells [25, 37, 38]. To 
confirm these ideas, melanocyte differentiation features 
and cell migration parameters were evaluated.
catalase overexpression increased melanocyte 
differentiation
Melanogenesis parameters were evaluated to verify 
whether the multipolarity found in A7 implies its evolution 
to a normal melanocyte. Results showed an increase in 
melanin content, TYR activity and TYRP1 expression 
in A7 compared with the amelanotic control (p < 0.05). 
Moreover, A7 increased the ability to proliferate after 
UV-A irradiation compared with control (p < 0.01) 
(Figure 3A–3D). Given that melanin protects melanocytes 
from UV radiation, these results indicate that A7 evolved 
to a melanotic and differentiated phenotype.
catalase overexpression induced melanoma cell 
migration
In order to evaluate if G10 had developed the 
ability to migrate, wound healing (Figure 4A and 4B) and 
transwell assay (Figure 4C) were performed. Increased 
migration was observed in G10 vs control and the other 
clones (p < 0.05) (Figure 4A–4C). Note that cells were 
not synchronized in terms of cell proliferation for wound 
healing. Therefore, considering that G10 as the other two 
clones are less proliferative, its increased migration could 
not be accounted for differences in proliferation rate.
Actin polymerization state, cofilin-1 and CAP1 were 
evaluated because of their relevance in cell migration. 
Increased actin fibers (F-actin) and F-actin aggregates in 
the leading edge of G10 cells were observed (Figure 5A). 
Furthermore, cofilin-1 and CAP1 expression increased in 
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G10 vs control (p < 0.05) (Figure 5A–5D). CAP1 was 
differentially located in protrusions of G10 cells with fiber 
actin (Supplementary Figure S2). These results indicate an 
increased actin polymerization state in G10 that favors its 
ability to migrate.
differential tumorigenicity was induced by 
catalase overexpression 
Regarding tumorigenesis, A7 induced pigmented 
tumors denoting increased differentiation, although they 
grew similar to controls (A375 and PCDNA3). On the 
contrary, tumors from G10 had more than 40 days delay 
in growth with significant decrease in size when compared 
to controls, even allowing to grow the same time since 
they appear, consistent with it less in vitro proliferation 
rate. C10 never induced tumors, even after 6 month since 
inoculation. No differences were found between controls 
(Figure 6A–6B). 
Representative images of H&E stained tumor tissue 
sections are shown (Supplementary Figure S3). High 
cell proliferation can be observed in tumors induced 
by controls and A7, but A7 tumors present areas with 
brownish granules of melanin deposits (Supplementary 
Figure S3), supporting the in vitro results of melanin 
synthesis and differentiation. On the other hand, 
G10 tumors were mostly necrotic. Note that as C10 did 
not induce tumors, no H&E/immunohistochemistry was 
performed.
Besides, an increased expression of TYRP1 in A7 
(p < 0.05) and of cofilin-1 and CAP1 in G10 compared 
with controls were found (p < 0.05) (Figure 6C–6D). 
These results confirmed in vivo that stable overexpression 
of catalase induced either melanogenesis or migration, 
which could be associated with the unchanged levels of 
ROS in A7 or its increased levels in G10. 
Considering the migration ability of G10, in vivo 
assay of tumor metastasis was performed. Pulmonary 
metastatic nodules were induced only by G10, indicating 
its evolution to a more aggressive phenotype (Figure 6E) 
and reinforcing the idea that its increased ROS levels 
could be associated with its malignant phenotype. 
dIscussIon
This work shows that overexpression of catalase in 
A375 melanoma cells inhibits proliferation in agreement 
with previous results [4, 39]. Besides, anchorage-
Figure 1: catalase-transfected A375 cells (A7, c10 and G10) decreased H2o2 levels but differentially induced ros 
levels. Control: A375 cells transfected with empty vector (PCDNA3) and not transfected (A375). (A) Representative immunoblot images 
of catalase and β-actin with its densitometric analysis. Actin values were used to normalize samples. Full length blots are included as 
Supplementary Figure S4. (b) Determination of catalase activity by spectrophotometric method. (c) Catalase mRNA expression by qPCR 
(d) Quantification of H2O2 production by Amplex® Red kit. (e–F) Intracellular ROS levels by quantification of DCF and MitoSOX Red 
mean fluorescence. Data are expressed as mean ± SD. *p < 0.05; **p < 0.01; ***p < 0.001 vs control (PCDNA3).
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independent cell growth inhibition was also found. 
However, the response to catalase overexpression led 
to quite distinct phenotypes that ranged from reversion 
to promotion of malignancy. When cells responded to 
H2O2 decrease increasing ROS levels, migration and 
metastasis were induced (G10), but when ROS levels did 
not change, less aggressive (A7) or nonmalignant (C10) 
phenotypes were generated.
Tumors progress with continuous ROS increase due 
to an AOS imbalance, which is characterized by low levels 
of catalase and glutathione peroxidase [4, 13, 39, 40]. 
Given that glutathione peroxidase activity and 
peroxiredoxin 2 expression did not change in these clones, 
H2O2 levels mainly decreased by the overexpression of 
catalase.
Besides, ERK1/2 activation increases proliferation 
[41]. Hydrogen peroxide can increase ERK1/2 activity by 
the oxidation of its phosphatases [42, 43]. These studies 
could explain how the decrease of H2O2 in these clones 
reduced its ERK1/2 activity together with cell proliferation 
and anchorage-independent cell growth. 
Dedifferentiation/differentiation are associated 
with more or less aggressive tumors [32, 33]. Clone 
A7 enhanced polarity with melanoma cell dendricity, 
a parameter of melanoma differentiation [34, 35]. 
Moreover, the activation of melanogenic pathway was 
observed in A7 by the increase in melanin content, 
tyrosinase activity and TYRP1 expression. The increase 
of catalase activity correlates with melanin content [16]. 
Pigmentation and melanocyte differentiation markers 
Figure 2: catalase overexpression down-regulated melanoma cell proliferation parameters and induced different cell 
polarity degree. A375 cells transfected with catalase (A7, C10 and G10) or not transfected (A375) relative to control, A375 cells 
transfected with empty vector (PCDNA3). (A) Cell proliferation rate evaluated by MTT assay. (b) Anchorage independent cell growth 
by soft agar assay. Results represent average number of colony per field, as described in supplementary material. (c–d) Representative 
immunoblot images of pERK, pAkt, total ERK and Akt. Full length blots are included as Supplementary Figure S4. Densitometric values 
of pERK or pAkt relative to total ERK or Akt respectively are shown. (e) Large to width cell ratio quantification. (F) Cell polarity degree 
was scored as shown in the cartoon below and presented as percentage of total cells scored. Cell scored/condition: 150. Data are expressed 
as mean ± SD. *p < 0.05; **p < 0.01; #p < 0.001 vs control.
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(tyrosinase and TYRP1) decreased by high H2O2 levels 
[15, 17]. Furthermore, tyrosinase and TYRP1 correlates 
inversely with tumor stage and its progression to the 
amelanotic phenotype [44–46]. Supporting the increased 
UV-A tolerance of A7, melanocytes offset deleterious 
effects of UV radiation by melanin and catalase [15, 47]. 
Therefore, these previous reports support how A7 turned 
to a differentiated and therefore less aggressive phenotype. 
Only A7 showed a significant decrease of Akt 
activity. In this regard, inhibition of Akt in melanoma 
cells increases melanogenesis pathway, by inducing MITF, 
meanwhile the inhibition of ERK did not [48, 49]. These 
previous studies could explain why melanogenesis was 
induced in A7 but not in C10 and G10. Thus, the induction 
of differentiation in A7 by catalase overexpression could 
be mediated by the inhibition of Akt activation, reinforcing 
its participation in the melanogenesis pathway.
Clone G10 showed a clear change towards 
dedifferentiation, revealed by the loss of polarity, 
characteristic of migration and metastasis progression 
[25, 38]. The fact that G10 increased ROS levels, although 
decreased H2O2, suggest that other ROS are responsible 
for the oxidative status of G10. The expression of proteins 
related to migration and metastasis induced by ROS [10] 
can explain the ability of G10 to migrate and metastasize. 
Therefore, switching to a migrating phenotype could be 
“an escape program” from high ROS levels [10]. In a 
mouse melanoma model, the antioxidant N-acetylcysteine 
Figure 3: catalase overexpression induced melanoma cell differentiation. A375 cells transfected with catalase (A7, C10 
and G10) relative to control, A375 cells transfected with empty vector (PCDNA3). (A) Melanin content determination in cell lysates by 
absorbance at 400 nm. Protein quantification was used to standardize cell samples. (b) TYR activity was evaluated indirectly by L-DOPA 
oxidase activity assay. Dopachrome levels were determined at 492 nm. (c) Representative immunoblot images of TYRP1 and β-actin 
protein expressions with its densitometric analysis. Actin densitometric values were used to normalize samples. Full length blots are 
included as Supplementary Figure S5. (d) Cell proliferation rate 24 and 48 hours post-UV radiation evaluated by MTT assay. Data are 
expressed as mean ± SD. *p < 0.05; **p < 0.01; #p < 0.001 vs control.
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(NAC) increased lymph node metastases but had no 
impact on the number and size of primary tumors [50]. 
These results agree with the metastatic ability and the 
small primary tumor size of G10. 
Melanoma cells invade and metastasize by 
amoeboid or mesenchymal migration [37, 38, 51]. 
Amoeboid migration, characteristic of round cells, is 
induced by actin-rich fillopodia at the leading edge of 
cells facilitating protrusions [24, 37], as observed in G10. 
Increase of cofilin-1 and CAP1 was found in G10. These 
proteins favors actin polymerization and so migration 
[29]. Cofilin-1 is a key factor in tumor cell migration 
and metastasis, being overexpressed in a wide variety 
of cancers [24, 26, 27, 52]. Cofilin-1 is activated by 
dephosphorylation through the phosphatase Slingshot-
1L (SSH-1L) [53, 54]. High levels of ROS activate 
cofilin-1 through the release of SSH-1L from its regulatory 
protein when oxidized by ROS, increasing cell migration 
[55]. Thus, high ROS production found in G10 could 
activate cofilin-1 by dephosphorylation. Colocalization 
of CAP1 with F-actin in the leading edge of cells has 
been involved in metastasis. Moreover, repression of 
cofilin-1 or CAP1 in metastatic cells inhibited migration 
[25, 31, 56, 57]. Therefore, not only the high levels of 
CAP1 and cofilin-1, but also the high ROS production 
found in G10 could be key events that promote migration 
and metastasis.
In vivo assays validated in vitro results. 
Tumorigenicity was completely inhibited in C10 and 
decreased in G10, consistent with the inhibition of 
proliferation and the antitumor effect of catalase [14, 58]. 
Even though A7 was tumorigenic, tumors were pigmented 
with increased expression of TYRP1. This confirms 
that A7 is a differentiated melanoma, which could be 
associated with a less aggressive phenotype. On the 
contrary, the increase of cofilin-1 and CAP1 together with 
the metastasis induced by G10 in vivo supports the fact 
that G10 evolved to an aggressive phenotype.
In conclusion, these cells faced H2O2 dissipation 
by two main strategies: maintaining or increasing ROS 
levels. Malignant features were reversed by catalase 
overexpression when ROS levels remained unchanged 
as demonstrated in C10 and A7. Moreover, when 
H2O2 scavenging was associated to Akt inactivation, 
Figure 4: catalase overexpression induced melanoma cell migration. A375 cells transfected with catalase (A7, C10 and G10) 
relative to control, A375 cells transfected with empty vector (PCDNA3). (A) Representative images of wound-healing assay, 0 and 48 hours 
post-wounding. Bar represents 200 µm. (b) Quantification of migration distance calculated as the average difference between the distance 
in arbitrary units (AU) at time 0 and 48 hours after wounding. (c) Evaluation of migration capacity by trans-well assay. Absorbance at 
560 nm indicates the amount of cells passing through membrane pores. Data are expressed as mean ± SD. *p < 0.05; **p < 0.01 vs control.
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melanogenesis pathway was triggered, as shown in 
A7 where TYRP1, tyrosinase and melanin content 
increased. On the other hand, when the response to catalase 
overexpression led to high ROS levels, amoeboid migration 
and actin polymerization were induced by both increasing 
cofilin-1 and CAP1 proteins, which are the driving force of 
migration and metastasis, as demonstrated in G10. 
The oxidative stress conditions that exist within 
the tumor and its microenvironment exert strong adaptive 
pressure on cancer cells, which in order to survive, promote 
the expression of ROS pathways reprogramming the 
transcriptome, proteome and metabolism [59]. Considering 
that H2O2 scavenging inhibits cell proliferation, we propose 
herein that melanoma cells triggered different responses 
to reach a redox homeostasis overcoming the effects 
on survival induced by catalase. Consistent with these 
idea, gene expression microarrays analysis of A7 and 
G10 [60] confirmed both in vitro and in vivo results and 
revealed coexpressed AOS genes upregulated in A7 and 
downregulated in G10, which could explain the different 
redox responses generated by each clone. Thus, even though 
it must be necessary to ascertain the results presented here 
in other cellular models, it is noteworthy that overexpression 
of an antioxidant enzyme, such as catalase, could favor 
not only the reversion of malignant processes but also the 
progression to a worse outcome. Therefore, taking into 
account that antioxidants can both, prevent or promote 
Figure 5: Catalase overexpression induced cofilin-1 and CAP1 expression. A375 cells transfected with catalase (A7, C10 and 
G10) relative to control, A375 cells transfected with empty vector (PCDNA3). (A) Representative immunocytofluorescence images of 
cofilin-1 with their corresponding actin and nuclear staining using rhodamine phalloidin and DAPI respectively. Bar represents 100 µm. 
Inset image of G10 exhibits its prominent F-actin and F-actin aggregates. (b) Quantification of cofilin-1 expression as the mean cell 
fluorescence arbitrary units (AU). (c–d) Representative immunoblot images of cofilin-1 and CAP1 protein expression with their respective 
densitometric analysis. Actin values were used to normalize samples. Full length blots are included as Supplementary Figure S5. Data are 
expressed as mean ± SD. *p < 0.05; **p < 0.01; ***p < 0.001 vs control. 
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cancer progression [50, 61–63], it is necessary to reconsider 
the use of antioxidants as a strategy against cancer without 
studying compensatory responses of the AOS.
In addition, the development of these stable clones 
with distinct characteristics in terms of antioxidant 
metabolism, pigmentation, migration and metastasis 
provides a new melanoma model for studying mechanisms 
associated with differentiation/dedifferentiation and 
malignant progression under the same genetic background. 
Finally, this work allowed proposing TYRP1, cofilin-1 
and CAP1 as potential markers to detect melanomas with 
varying degrees of aggressiveness. 
Figure 6: In vivo validation of in vitro results in tumors induced by melanoma cells overexpressing catalase. Nude 
mice inoculated with A375 cells transfected with catalase (A7, C10 and G10), with empty vector (PCDNA3) or not transfected (A375). 
(A) Tumor growth curves over time post-inoculation by monitoring tumor volume throughout time. (b) Representative images of mice 
inoculated with each cell type and the respective tumors of the tumorigenic ones: A375, PCDNA3, A7 and G10. (c) Representative images 
of TYRP1, cofilin-1 and CAP1 IHC detection in tissue sections of tumors induced by A375, PCDNA3, A7 and G10 cells. Bar represents 
50 µm. (d) Quantification of IHC by optic densitometric (OD) analysis of images. Data are expressed as mean ± SD. *p < 0.05; #p < 0.001 
vs control (PCDNA3). (e) Lung tissue sections stained with H&E. Representative images of G10 lung nodules indicate its metastatic 
ability. Control lung tissue section is also shown. Black bars represent 500 µm and white bar 100 µm.
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MAterIAls And MetHods
cell culture and catalase overexpression 
melanoma model
Low-passages human amelanotic melanoma cell line 
A375 was kindly donated by Dr. E. Medrano (Huffington 
Center on Aging, Departments of Molecular & Cellular 
Biology and Dermatology, Baylor College of Medicine, 
Houston, Texas, USA). All the experiments with these 
cells were performed with less than 5 passages from 
thawing. Cells were cultured as previously described 
[4]. Stable transfected cells were maintained in identical 
conditions with 700 µg/ml geneticin (Sigma). Cells were 
regularly tested to be mycoplasma-free.
A375 cells were transfected with pcDNA3 vector 
harboring the human catalase cDNA (p-CAT) using 
Lipofectamine 2000 (Invitrogen) [4]. Stable transfectants 
were selected in medium with 1500 µg/ml geneticin. Three 
resistant clones A375-A7, A375-C10 and A375-G10, 
referred in this work as A7, C10 and G10 respectively, 
were obtained by clonal dilution. Given that catalase 
inhibits cell proliferation only three clones were possible 
to obtain. Transfected cells with empty vector were used 
as negative control and named A375-PCDNA3, referred 
here as PCDNA3. 
In vitro experiments
determination of catalase and redox parameters
Catalase mRNA expression was determined by 
quantitative real-time PCR (qPCR). Forward and reverse 
primer sequences were: 5ʹcctttctgttgaagatgcggcgʹ3 and 
5ʹggcggtgagtgtcaggatagʹ3 respectively. Cycling conditions 
are detailed in Supplementary Table S1. For protein 
expression western blot was performed using anti-catalase 
antibody (Calbiochem, EMD Milipore) and the detection 
of β-actin (Sigma antibody) as loading control. Catalase 
activity was measured using a spectrophotometric assay [4]. 
The intracellular levels of H2O2 were evaluated 
by spectrophotometry according to Amplex® Red kit 
(Invitrogen). A standard curve of H2O2 was performed. 
Results were expressed as H2O2 nmol released in 30 min 
per protein μg.
The levels of ROS were determined by 2ʹ,7ʹ-
dichlorodihydro-fluorescein diacetate (DCFH-DA, Sigma) 
assay [64] and MitoSOX™ Red (Invitrogen) [65].
Glutathione peroxidase (GPx) activity was measured 
by an indirect spectrophotometric assay [66, 67]. 
Peroxiredoxin 2 expression was detected by western blot 
using anti-peroxiredoxin 2 (Sigma) and β-actin antibody 
(Sigma) as loading control.
determination of cell proliferation parameters
Proliferation was determined by MTT assay [68]. 
Anchorage independent cell growth was evaluated by soft 
agar colony formation assay.
The levels of the active form of ERK1/2 and Akt 
(p-ERK1/2 and p-Akt) related to the total form of these 
proteins were detected by western blot as a measure of 
their activity. 
cell polarity
Cell polarity was evaluated by measuring the 
cell length/width ratio (L/W) and cells were classified 
as apolar, unipolar, bipolar or multipolar as shown in 
Figure 2F [25].
determination of melanogenesis parameters
Melanin content was evaluated in cell lysates by 
spectrophotometry at 400 nm and expressed per protein 
mg. Tyrosinase activity was assayed by measuring the 
L-3, 4-dihydroxyphenylalanine (L-DOPA) oxidase 
activity. The dopachrome levels were determined at 
492 nm [69]. TYRP1 expression was assessed by western 
blot using anti-TYRP1 antibody (Abcam) and β-actin 
antibody (Sigma) as loading control. 
cell response to uV-A radiation
After 24 hours culture, 5000 cells were irradiated 
with 29 kJ/m2 total irradiation dose [70].
Cell proliferation was evaluated 24 and 48 hours 
post irradiation through MTT assay.
cell migration: Wound healing and transwell assay
A scratch in the cell monolayer was performed 
and migration extent was evaluated at 48 hours after 
healing. Transwell migration assay was performed using 
the CytoSelect™ Cell Migration Assay Kit, according to 
manufacturer’s indications (Cell Biolabs, Inc). 
Evaluation of cofilin-1, CAP1 and actin polymerization 
state
Standard immunocytofluorescence and western 
blot using anti-cofilin-1 or anti-CAP1 antibodies 
(Abcam) were performed. Detection of β-actin (Sigma 
antibody) was used as loading control in western blot. 
Rhodamine-phalloidin (Sigma) staining was used for actin 
visualization. 
In vivo experiments
Six-week-old female athymic nude (nu/nu) mice 
were obtained from the CNEA animal facility (Argentina). 
Animals were kept under conventional housing conditions. 
To evaluate the in vivo effect by catalase overexpression, 
tumors and metastasis were induced by injecting 2.5 × 106 
cells subcutaneously in one flank or through the tail vein 
respectively, using 5 animals per experimental condition. 
As control of cell viability of tail vein inoculated 
cells at the moment of injection, cells were inoculated 
subcutaneously in 2 nude mice per condition. All 
procedures were carried out according to the Laboratory 
Animal Care and Use guidelines from CNEA and to the 
relevant international guidelines.
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evaluation of tumor growth and metastasis
Tumor growth was evaluated by determining tumor 
volume every other day during up to 3 month. To study the 
development of metastasis, mice autopsy was conducted. 
Tumors and organs with naked eyes metastasis were 
processed for histopathological examination (H&E) and 
immunohistochemistry.
Immunohistochemistry detection of TYRP1, cofilin-1 
and CAP1 
Standard immunohistochemistry was performed 
using proper antibodies and Super Sensitive IHC 
Detection Systems (BioGenex) or Picture-MAX Polymer 
(Invitrogen) kits following manufacturer’s instructions. 
Rabbit anti-TYRP1, cofilin-1 and CAP1 antibodies 
(Abcam) were used.
statistical analysis
Significant differences between group means were 
assessed by one-way analysis of variance followed by 
Dunn’s multiple comparisons test. For tumor growth 
analysis, when parametric tests were not possible to apply, 
Friedman test for matched observations was performed 
followed by Dunnett’s multiple comparisons test. P-values 
lower than 0.05 were considered significant for all tests.
Detailed description of all methods is included in 
Supplementary Materials.
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